NASDAQ:BWIN • US05589G1022
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BALDWIN INSURANCE GROUP INC/ (BWIN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-09 | UBS | Maintains | Buy -> Buy |
| 2026-02-27 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-27 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2026-01-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-07 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-12-12 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2025-12-05 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-12-04 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-11-11 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-11-10 | UBS | Maintains | Buy -> Buy |
| 2025-11-05 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-10-13 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-10-09 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-08 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-08-07 | Raymond James | Downgrade | Strong Buy -> Outperform |
| 2025-07-10 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-06-13 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-04-11 | Jefferies | Maintains | Hold -> Hold |
| 2025-04-10 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-04-08 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-03-27 | BMO Capital | Initiate | Outperform |
| 2025-02-26 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-02-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-14 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-01-10 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.219B 24.25% | 1.389B 13.99% | 1.505B 8.34% | 2.045B 35.89% | 2.279B 11.44% | 2.496B 9.52% | 2.723B 9.09% | |
| EBITDA YoY % growth | 55.851M -2.97% | 169.572M 203.61% | 201.766M 18.99% | 478.25M 137.03% | 566.45M 18.44% | 651.44M 15.00% | 676.26M 3.81% | |
| EBIT YoY % growth | -42.551M -47.76% | 60.648M 242.53% | 73.936M 21.91% | 112.54M 52.21% | 154.1M 36.93% | 281.52M 82.69% | 351.9M 25.00% | |
| Operating Margin | -3.49% | 4.37% | 4.91% | 5.50% | 6.76% | 11.28% | 12.92% | |
| EPS YoY % growth | 1.12 8.74% | 1.50 33.93% | 1.69 12.67% | 2.07 22.40% | 2.58 24.91% | 3.17 22.84% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.65 0.13% | 0.50 20.19% | 0.44 40.74% | 0.43 39.84% | 0.90 38.17% | 0.68 34.30% | 0.59 34.89% | 0.56 28.16% | 0.99 10.13% | 0.75 10.73% | 0.63 7.80% |
| Revenue Q2Q % growth | 536.78M 29.84% | 513.72M 35.61% | 475.77M 30.21% | 448.02M 29.01% | 583.57M 8.72% | 545.07M 6.10% | 532.95M 12.02% | 517.27M 15.46% | 668.45M 14.54% | 619.12M 13.59% | 593.92M 11.44% |
| EBITDA Q2Q % growth | 139.27M 66.83% | 117.05M 40.93% | 106.26M 17.58% | 97.676M -14.76% | 172.05M 23.54% | 139.11M 18.85% | 124.91M 17.55% | 120.43M 23.30% | N/A | N/A | N/A |
| EBIT Q2Q % growth | 86.935M 55.19% | 60.134M 115.23% | 45.73M 1,321.95% | 22.242M 268.03% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
16 analysts have analysed BWIN and the average price target is 34.83 USD. This implies a price increase of 65.36% is expected in the next year compared to the current price of 21.06.
BALDWIN INSURANCE GROUP INC/ (BWIN) will report earnings on 2026-05-04, after the market close.
The consensus EPS estimate for the next earnings of BALDWIN INSURANCE GROUP INC/ (BWIN) is 0.65 USD and the consensus revenue estimate is 536.78M USD.
The number of analysts covering BALDWIN INSURANCE GROUP INC/ (BWIN) is 16.